Clinical Evidence
Evidence from clinical and bench investigations suggest that CCM® therapy improves the heart’s contractility, as it is designed to do, by modifying the function and expression of proteins in the heart muscle. Clinical trials have demonstrated statistically significant and clinically meaningful improvements in the FIX-HF-5C randomized trial:
- CCM® subjects improved 11.7 points in the MLWHFQ score compared to the control group.
- CCM® subjects improved their NYHA heart failure status by >1 class 81% of the time compared to 42% in the control group.
- CCM® subjects walked on average 33.7 meters further than the control group during the 6-minute hall walk test
The approach has proven to be safe and effective in numerous clinical studies, including several randomized controlled trials, and the results have been published in over 90 articles appearing in leading medical journals.4 |